Merck scraps Covid-19 vaccine programs after they fail to measure up on efficacy in another major setback in the global fight
After turning up late to the vaccine development game in the global fight against Covid-19, Merck is now making a quick exit.
The pharma giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
